SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-019987
Filing Date
2019-10-08
Accepted
2019-10-08 16:30:20
Documents
2
Period of Report
2019-10-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k100719_inmunebio.htm 8-K 16720
2 INMUNE BIO PRESS RELEASE f8k100719ex99-1_inmunebio.htm EX-99.1 10875
  Complete submission text file 0001213900-19-019987.txt   28721
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 191142945
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences